Cargando…

MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis

INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Neeti, Sena, Maria, Ghaffari, Gisoo, Ishmael, Faoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457706/
https://www.ncbi.nlm.nih.gov/pubmed/32923026
http://dx.doi.org/10.1177/2152656720953378
_version_ 1783576050516623360
author Bhardwaj, Neeti
Sena, Maria
Ghaffari, Gisoo
Ishmael, Faoud
author_facet Bhardwaj, Neeti
Sena, Maria
Ghaffari, Gisoo
Ishmael, Faoud
author_sort Bhardwaj, Neeti
collection PubMed
description INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (EGD) continues to be the gold standard for diagnosis and monitoring of response to therapy. There is a growing necessity for non-invasive biomarkers that can accurately diagnose this condition and assess response to therapy. While microRNAs (miRNA) are being investigated in allergic diseases, including EoE, not many studies have explored the role of salivary miRNAs in EoE. MiR-4668-5p is a particularly interesting candidate, as it is predicted to regulate TGF-beta signaling and has not previously been identified as a target in any allergy disease. We sought to further investigate the role of miR-4668 as a biomarker to characterize and monitor response to treatment with swallowed topical glucocorticoids. METHODS: After IRB approval, twenty-two adult patients with EoE were randomly enrolled to provide a saliva sample before and after 2 months of swallowed fluticasone therapy. Differences of miRNA expression before and after treatment were analyzed by paired T-test. A significance cutoff of <0.05 was used for all analyses. RESULTS: Expression of miR-4668 was higher in EoE vs. non-EoE subjects. The level of miR-4668 decreased in all subjects except one, with a mean fold change 0.49 ± 0.25. There was an association between miRNA expression and number of positive aeroallergens. The miR-4668 high group had a higher number of positive aeroallergen tests, while the miR-4668 low group had a greater number of subjects with drug allergies. CONCLUSIONS: In this study, we identified that salivary miRNAs may serve as biomarkers to characterize EoE and response to topical corticosteroids. We specifically identified miR-4668 as a novel potential biomarker, which was not previously discovered as a target in EoE or any other allergic disease.
format Online
Article
Text
id pubmed-7457706
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74577062020-09-11 MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis Bhardwaj, Neeti Sena, Maria Ghaffari, Gisoo Ishmael, Faoud Allergy Rhinol (Providence) Original Research INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (EGD) continues to be the gold standard for diagnosis and monitoring of response to therapy. There is a growing necessity for non-invasive biomarkers that can accurately diagnose this condition and assess response to therapy. While microRNAs (miRNA) are being investigated in allergic diseases, including EoE, not many studies have explored the role of salivary miRNAs in EoE. MiR-4668-5p is a particularly interesting candidate, as it is predicted to regulate TGF-beta signaling and has not previously been identified as a target in any allergy disease. We sought to further investigate the role of miR-4668 as a biomarker to characterize and monitor response to treatment with swallowed topical glucocorticoids. METHODS: After IRB approval, twenty-two adult patients with EoE were randomly enrolled to provide a saliva sample before and after 2 months of swallowed fluticasone therapy. Differences of miRNA expression before and after treatment were analyzed by paired T-test. A significance cutoff of <0.05 was used for all analyses. RESULTS: Expression of miR-4668 was higher in EoE vs. non-EoE subjects. The level of miR-4668 decreased in all subjects except one, with a mean fold change 0.49 ± 0.25. There was an association between miRNA expression and number of positive aeroallergens. The miR-4668 high group had a higher number of positive aeroallergen tests, while the miR-4668 low group had a greater number of subjects with drug allergies. CONCLUSIONS: In this study, we identified that salivary miRNAs may serve as biomarkers to characterize EoE and response to topical corticosteroids. We specifically identified miR-4668 as a novel potential biomarker, which was not previously discovered as a target in EoE or any other allergic disease. SAGE Publications 2020-08-28 /pmc/articles/PMC7457706/ /pubmed/32923026 http://dx.doi.org/10.1177/2152656720953378 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Bhardwaj, Neeti
Sena, Maria
Ghaffari, Gisoo
Ishmael, Faoud
MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title_full MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title_fullStr MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title_full_unstemmed MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title_short MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
title_sort mir-4668 as a novel potential biomarker for eosinophilic esophagitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457706/
https://www.ncbi.nlm.nih.gov/pubmed/32923026
http://dx.doi.org/10.1177/2152656720953378
work_keys_str_mv AT bhardwajneeti mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis
AT senamaria mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis
AT ghaffarigisoo mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis
AT ishmaelfaoud mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis